纳米载药系统逆转肿瘤及骨肉瘤多药耐药的研究进展
投稿时间:2014-12-21  修订日期:2015-05-06  点此下载全文
引用本文:陈自强,张玮,李玉平,王晓宇.纳米载药系统逆转肿瘤及骨肉瘤多药耐药的研究进展[J].药学实践杂志,2016,34(2):103~105
摘要点击次数: 1402
全文下载次数: 11
作者单位
陈自强 第二军医大学附属长海医院骨科, 上海 200433 
张玮 同济大学附属上海市肺科医院药剂科, 上海 200433 
李玉平 同济大学附属上海市肺科医院药剂科, 上海 200433 
王晓宇 第二军医大学附属长海医院药学部, 上海 200433 
中文摘要:多药耐药是肿瘤化疗中的重要难题,多药耐药的机制复杂,目前尚无有效的治疗策略。纳米载药系统具有靶向性、载药种类多样等优点,近年来成为对抗肿瘤多药耐药的递药载体的重要研究方向。对肿瘤抑制的不同机制进行讨论,并对纳米载药系统逆转骨肉瘤多药耐药的研究进展进行综述。
中文关键词:肿瘤  骨肉瘤  多药耐药  纳米载药系统
 
Progress on nano-sized drug delivery system reversing tumor and multidrug resistance of osteosarcoma
Abstract:Multidrug resistance(MDR) of tumor cell is the major problem for chemotherapy. However, there is no effective strategy to overcome MDR due to the complicated mechanism. The nano-sized drug delivery system could target to the tumor cell. Moreover, it could delivery different kinds of drugs. Therefore, the nano-sized drug delivery system has become a promising approach to reverse MDR. The nano-sized drug delivery system which is applied to treat the MDR of tumor(osteosarcoma) was summarized and the reverse mechanism was discussed.
keywords:tumor  osteosarcoma  MDR  nano-sized drug delivery system
查看全文  查看/发表评论  下载PDF阅读器
关闭

分享按钮